Literature DB >> 12054463

Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite.

Katrina M Miranda1, Ken-ichi Yamada, Michael G Espey, Douglas D Thomas, William DeGraff, James B Mitchell, Murali C Krishna, Carol A Colton, David A Wink.   

Abstract

The nitroxyl (HNO) donor Angeli's salt (Na(2)N(2)O(3); AS) is cytotoxic in vitro, inducing double strand DNA breaks and base oxidation, yet may have pharmacological application in the treatment of cardiovascular disease. The chemical profiles of AS and synthetic peroxynitrite (ONOO(-)) in aerobic solution were recently compared, and AS was found to form a distinct reactive intermediate. However, similarities in the chemical behavior of the reactive nitrogen oxide species (RNOS) were apparent under certain conditions. Buffer composition was found to have a significant and unexpected impact on the observed chemistry of RNOS, and varied buffer conditions were utilized to further distinguish the chemical profiles elicited by the RNOS donors AS and synthetic ONOO(-). Addition of HEPES to the assay buffer significantly quenched oxidation of dihydrorhodamine (DHR), hydroxylation of benzoic acid (BA), and DNA damage by both AS and ONOO(-), and oxidation and nitration of hydroxyphenylacetic acid by ONOO(-). Additionally, H(2)O(2) was produced in a concentration-dependent manner from the interaction of HEPES with both the donor intermediates. Interestingly, clonogenic survival was not affected by HEPES, indicating that H(2)O(2) is not a contributing factor to in vitro cytotoxicity of AS. Variation in RNOS reactivity was dramatic with significantly higher relative affinity for the AS intermediate toward DHR, BA, DNA, and HEPES and increased production of H(2)O(2). Further, AS reacted to a significantly greater extent with the unprotonated amine form of HEPES while the interaction of ONOO(-) with HEPES was pH-independent. Addition of bicarbonate only altered ONOO(-) chemistry. This study emphasizes the importance of buffer composition on chemical outcome and thus on interpretation and provides further evidence that ONOO(-) is not an intermediate formed between the reaction of O(2) and HNO produced by AS. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054463     DOI: 10.1016/S0003-9861(02)00031-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  27 in total

Review 1.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  The shy Angeli and his elusive creature: the HNO route to vasodilation.

Authors:  Nazareno Paolocci; David A Wink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 4.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

5.  Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.

Authors:  Marianne Tare; Rushita S R Kalidindi; Kristen J Bubb; Helena C Parkington; Wee-Ming Boon; Xiang Li; Christopher G Sobey; Grant R Drummond; Rebecca H Ritchie; Barbara K Kemp-Harper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-10       Impact factor: 3.000

6.  Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors:  Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2014-09-02       Impact factor: 4.427

7.  Biological signaling by small inorganic molecules.

Authors:  Debashree Basudhar; Lisa A Ridnour; Robert Cheng; Aparna H Kesarwala; Julie Heinecke; David A Wink
Journal:  Coord Chem Rev       Date:  2016-01-01       Impact factor: 22.315

8.  A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system.

Authors:  Katrina M Miranda; Nazareno Paolocci; Tatsuo Katori; Douglas D Thomas; Eleonora Ford; Michael D Bartberger; Michael G Espey; David A Kass; Martin Feelisch; Jon M Fukuto; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-15       Impact factor: 11.205

9.  Kinetic feasibility of nitroxyl reduction by physiological reductants and biological implications.

Authors:  Matthew I Jackson; Tae H Han; Laura Serbulea; Andrew Dutton; Eleonora Ford; Katrina M Miranda; K N Houk; David A Wink; Jon M Fukuto
Journal:  Free Radic Biol Med       Date:  2009-07-02       Impact factor: 7.376

10.  Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.

Authors:  Sonia Donzelli; Gerry Fischer; Bruce S King; Christin Niemann; Jenna F DuMond; Jörg Heeren; Hartwig Wieboldt; Stephan Baldus; Christian Gerloff; Thomas Eschenhagen; Lucie Carrier; Rainer H Böger; Michael Graham Espey
Journal:  J Pharmacol Exp Ther       Date:  2012-12-04       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.